Celldex Therapeutics Cash from Investing (TTM) Insights

Celldex Therapeutics Inc (CLDX)

37.92 -0.56 (-1.46%) USD | NASDAQ | Apr 19, 16:00

37.92 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 1991. Upgrade now.

Date	Value
December 31, 2023	-105.78M
September 30, 2023	96.59M
June 30, 2023	108.01M
March 31, 2023	132.13M
December 31, 2022	89.94M
September 30, 2022	39.78M
June 30, 2022	-210.07M
March 31, 2022	-249.26M
December 31, 2021	-216.16M
September 30, 2021	-166.36M
June 30, 2021	17.92M
March 31, 2021	-76.70M
December 31, 2020	-98.22M
September 30, 2020	-125.85M
June 30, 2020	-77.82M
March 31, 2020	22.75M
December 31, 2019	17.08M
September 30, 2019	17.20M
June 30, 2019	9.464M
March 31, 2019	30.62M
December 31, 2018	29.82M
September 30, 2018	13.09M
June 30, 2018	16.97M
March 31, 2018	39.56M
December 31, 2017	46.47M

Date	Value
September 30, 2017	87.63M
June 30, 2017	100.89M
March 31, 2017	65.77M
December 31, 2016	68.91M
September 30, 2016	59.87M
June 30, 2016	57.21M
March 31, 2016	40.38M
December 31, 2015	-50.19M
September 30, 2015	-51.24M
June 30, 2015	-45.48M
March 31, 2015	-24.72M
December 31, 2014	-41.01M
September 30, 2014	-72.53M
June 30, 2014	-84.99M
March 31, 2014	-112.17M
December 31, 2013	-77.42M
September 30, 2013	-68.14M
June 30, 2013	-67.71M
March 31, 2013	-36.05M
December 31, 2012	-16.98M
September 30, 2012	-4.399M
June 30, 2012	-0.034M
March 31, 2012	-34.93M
December 31, 2011	-2.155M
September 30, 2011	-2.687M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-249.26M

Minimum

Mar 2022

132.13M

Maximum

Mar 2023

-40.81M

Average

9.464M

Median

Jun 2019

Cash from Investing (TTM) Benchmarks